Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients
Clinical trial NCT02654145 · COMPLETED
Trial details
- NCT number
- NCT02654145
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-17
- Primary completion
- 2017-05-31
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.